Adglim M1 Tablet

Introduction to Adglim M1 Tablet

Adglim M1 Tablet is a combination of Glimepiride and Metformin which belongs to a group of medicines called Antidiabetic agents. Adglim M is used to treat type 2 diabetes mellitus when diet, exercise and the single agent does not result in adequate glycemic control.

Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin, or the produced insulin does not work well. Symptoms include excessive urination, excessive thirst, hunger, fatigue, and blurred vision.

Glimepiride lowers blood sugar by causing the pancreas to produce more insulin and helps the body use insulin efficiently. Metformin is a biguanide which effectively reduces the total amount of sugar released into the blood by the liver.

Uses of Adglim M1

• Treat Type 2 Diabetes
• Controls high blood sugar levels
• Stimulates insulin release
• Reduces glucose production
• Prevents long-term diabetic complications

How Does Adglim M 1 Works?

Adglim M controls blood glucose levels, where glimepiride works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin works by lowering glucose production in the liver, delaying glucose absorption from intestine, and increasing the body’s sensitivity to insulin.

Side Effects of Adglim M1

How to Manage Side Effects?

• Contact Your Doctor
• Do Not Stop Abruptly
• Follow Prescribed Dosage
• Take with Food
• Monitor Blood Sugar Levels
• Stay Hydrated
• Discuss Alternative Medications
• Lifestyle Modifications

Warnings & Precautions 

1. Risk of Hypoglycemia:

• Adglim M1 can cause low blood sugar, especially if meals are skipped, or taken with other anti-diabetic drugs or alcohol.

2. Lactic Acidosis Warning:

• The Metformin component may rarely cause lactic acidosis, a serious condition requiring immediate medical attention. Risk increases with kidney, liver, or heart disease.

3. Not for Type 1 Diabetes:

• Adglim M1 is only for type 2 diabetes and is not suitable for type 1 diabetes or diabetic ketoacidosis.

4. Kidney Function Monitoring:

• Use with caution in patients with kidney issues; regular renal function tests are necessary.

5. Alcohol Use:

• Avoid alcohol, as it increases the risk of both hypoglycemia and lactic acidosis.

6. Surgery or Imaging Procedures:

• Temporarily stop Adglim M1 before surgery or radiologic procedures using contrast dye to reduce lactic acidosis risk.

7. Pregnancy and Breastfeeding:

• Use only if clearly needed and prescribed by a doctor; safety in pregnant or nursing women is not fully established.

8. Vitamin B12 Deficiency:

• Long-term use may reduce B12 levels; monitoring may be required.

Storage 

• Store Adglim M1 below 30°C in a cool, dry place.
• Keep away from moisture, heat, and direct sunlight.
• Do not refrigerate or freeze the tablets.
• Store in the original packaging or container.
• Keep out of reach of children and pets.
• Discard any expired or damaged tablets properly.
• Check for changes in color, shape, or texture before use.

Frequently Asked Questions

1. Can I stop taking Adglim M1 Tablet 10’s on my own?

Ans. You are not recommended to stop taking Adglim M Tablet 10’s on your own as discontinuing Adglim M Tablet 10’s suddenly may cause recurring symptoms or worsen the condition. However, if you experience any difficulty while taking Adglim M Tablet 10’s, please consult your doctor so that alternative medicine may be prescribed.

2. Is Adglim M safe to use in patients with kidney problems?

Ans. Adglim M is not recommended for use in patients with severe kidney disease and it should be used with caution in patients with kidney disease and your dose will be adjusted if needed depending upon kidney function. Consult your doctor before taking Adglim M.

3. Can I consume alcohol while taking Adglim M?

Ans. Avoid consumption of alcohol during treatment with Adglim M as it may increase or decrease the blood sugar lowering action of Adglim M and increases the risk of lactic acidosis. Consult your doctor for advice before taking Adglim M.